Global Sterile and Antiviral Packaging Market

The sterile and antiviral packaging market was reached at USD 35.4 Billion, and it is estimated to reach USD 68.49 Billion in 2028 with a GAGR of 8.1% during the forecast period of 2022-2028. Expansion in the market is noticed due to the demand for surface sterilization of an expansive range of medical devices utilized in clinical. Plastic has tremendous application in antiviral and sterile packaging, such as thermoformed trays, pouches, clamshells, etc. They can be materialized into different shapes, maintain increased barrier belongings, and move the market’s growth. With all the possessions of plastics and economic and value-based approach, manufacturers are also marketing with plastic and boosting the production of the market and will develop growth prospects for the sterile and antiviral packaging market.

What is Sterile and Antiviral Packaging?

Sterilization is an important processing action conducted in the healthcare industry. Hence, utilizing sterile and antiviral packaging products or barrier systems has achieved considerable prominence in this industry. Sterile medical packaging is a non-reusable packaging material that acts as a barrier against microbial transmission. Most of these packaging, such as wraps, pouches, and containers, are designed to control medical products from the outer environment and unwilling communication of infections.

Growth Drivers

Increasing Demand in Healthcare Industry

Sterilization is an important processing action conducted in the healthcare industry. Hence, utilizing sterile packaging products or barrier systems has achieved considerable prominence in this industry. Sterile medical packaging is a non-reusable packaging material that acts as a barrier against microbial transmission. Most of these packaging, such as wraps, pouches, and containers, are designed to control medical products from the outer environment and unwilling communication of infections.

Opportunities

Increasing Adoption of Single-use Medical Equipment is a Prominent Trend

The increasing chances of infectious diseases such as coronavirus, cold, flu and tuberculosis have shown a ripple in demand for single-use medical supplies or devices. These devices include syringes, needles, bandages, face masks, gloves, applicators, suction catheters, testing kits, and surgical sponges. These devices are utilized only once, preventing bacteria or infection from one patient to another. The packaging utilized for such devices requires very efficient in maintaining their sterility. These products are supposed to be effective packaging solutions for such appliances. They keep the single-use medical equipment away from moisture and chemicals. These packaging solutions are obtainable in different sizes and shapes according to the condition of the application area. Therefore, the rising market for single-use medical equipment will fuel the market.

Restraints

Strict Regulatory Standards for Sterile and Antiviral Packaging to Bound Sterile and Antiviral Packaging Market Growth

Sterile and antiviral packaging procedures must be developed to deliver sterility of packed contents until their moment of use. Therefore, strict regulatory measures are made and executed over their manufacturing. These standards ensure that the sealed devices or instruments do not face any negative response or damage from packaging products or external factors. EN ISO 11607 is the global standard determining medical packaging systems’ warranty requirements for sterilized medical devices or instruments. These validation requirements are used in various packaging products, such as material selection, design qualification, design testing & control, and process validation. The standards are complex and act as a restraining factor for the market.

Pre Covid-19 Impact on Global Sterile and Antiviral Packaging Market

Before the covid-19 explosion, due to an increase in attention concerning sterilization procedures, rise in demand for single-use medical equipment, the surge in usage of sterile packaging systems, growth in the number of developed hospitals & clinics all over the globe, and rise in the patient suffering from chronic conditions are the essential elements that push the growth of the market before the covid-19 situation. In addition, the surge in healthcare awareness among consumers regarding sterile medical supplies, rise in adoption of advanced healthcare devices, increase in demand of disposable devices by ambulatory surgical centers, ongoing development of single disposable use sterile packaging factors that boost the growth of the sterile medical packaging market.

Covid-19 Impact on Global Sterile and Antiviral Packaging Market

During the Covid-19 outbreak, Pharmaceutical and biotech firms, jointly with governments nearly the globe, are working to address the COVID-19, from supporting the development of vaccines to preparing for medicine supply chain challenges. Around 115 vaccine candidates and 155 molecules are currently in the R&D pipeline. Moreover, generally used medicines such as Hydroxychloroquine have noticed a surprising surge in demand for the management of COVID-19. Such a high need for these medicines has offered huge possibilities for manufacturers of COVID-19 management drugs, as many progressive nations face a shortage of these medicines. Thus, the pharmaceutical and biotechnology industry is anticipated to notice considerable growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. It, in turn, is foreseen to maintain a powerful influence on the sterile and antiviral packaging market.

Post Covid-19 Impact on Global Sterile and Antiviral Packaging Market

After the covid-19 explosion, the pandemic has pushed an impulsive demand for diagnostic examinations, personal shielding equipment, medical ventilators, and other essential medical supplies. Therefore, the demand for sterile/aseptic, antiviral, and new bearable packaging options has surged. However, the extra demand for healthcare products has caused a lack of supply, according to the Annals of Intern Medicine. As governments in these nations are taking endeavors to normalize the working of their industries, the market is anticipated to regularize after the covid-19 period.

By Packaging type Segmental Analysis

Based on the packaging type segment, the market is classified into Thermoform Trays, Sterile Bottles/Containers, Vials & Ampoules, sterile Closures, Pre-Filled Syringes, Blister & Clamshells, IV Bags & Pouches and Sterile Wraps. The thermoform trays segment is cast to register the highest CAGR. These are universally adaptable and comfortable to transport because of their lower weight. Thermoformed trays are simulated from plastics, come in various shapes and sizes, and are provided for internal use.

By Material Segmental Analysis

Based on the segmental material analysis, the market is classified into Plastics, Glass, Metal Paper & Paperboard. The plastic sterile and antiviral packaging segment is expected to lead the sterile and antiviral packaging market. This growth can be bifurcated to increased consumption and increasing need from end-users. Plastic polymers, such as HDPE, polyester, and polypropylene, are used broadly in manufacturing bottles, vials & ampoules, and pre-filled syringes in the sterile and antiviral packaging market.

By segmental Application Analysis

The market is segmented into Pharmaceuticals & Biological, Surgical & Medical Instruments and Food & beverage packaging. The pharmaceutical & biological segment is predicted to show the sterile and antiviral packaging market during the forecast period. The development of this segment can be attributed to the growing healthcare industry and the start of new healthcare treatments. Technological improvements have optimized and incorporated the sterile and antiviral packaging method of pharmaceutical products and caused it to be more capital-intensive. This technique decreases the threat of contamination. The processing and packaging of pharmaceutical & biological effects go through different inspections quality checks and ensure that they stick to regulatory obedience about the drug contents and the material used in packaging.

By Regional Segmental Analysis

Based on regional segment, the market is classified into North America, Europe, Asia-Pacific, South America and The Middle East & Africa. North America has calculated the largest share and is expected to detect the highest growth during the forecast period. This growth can be attributed to multiple restrictions levied by the FDA, which propels the demand for sustainable and high-quality products in this region. Moreover, owing to many prominent players and strict FDA rules, the market has evolved very competitively in the area.

Competitor’s analysis

The Companies include Amcor Limited, DuPont De Nemours, Inc., 3M Company, West Pharmaceutical Services, Inc., ProAmpac, Sonoco, Tekni-Plex, Orchid, Oliver Healthcare Packaging, Technipaq and other prominent players in the global sterile and antiviral packaging market. Key Stakeholders

• Market research and consulting firms
• Sterile and Antiviral Packaging Associates
• Local Governments
• Regulatory bodies
• Sterile and Antiviral Packaging Market
• Suppliers
• Retailers
• Service Providers

Recent Developments

• In June 2019, Amcor finalized the purchase of Bemis. This strategic combination inaugurates Amcor as the global authority in consumer packaging with a comprehensive global footprint, scale in every region, and industry-leading R&D credentials.
• In September 2017, DuPont declared the opening of DuPont Tyvek 40L medical packaging, a new class of Tyvek for medical packaging applications that delivers a cost-effective option for protecting lightweight, low-risk machines.
• In October 2019, 3M completed the investment of Acelity, Inc. and its KCI subsidiaries worldwide. Acelity is a top global medical technology company concentrated on progressive wound care and specialty surgical applications marketed under the KCI brand. This acquisition revved 3M as a leader in advanced wound care, a substantial and expanding market segment.
• In February 2020, West Pharmaceutical Services established two-line attachments, including its AccelTRA Select EU configurations available in Ready-to-Sterilize (RS) and Ready-to-Use (RU) steam for customers needing a high-performing elastomer and regulatory support in North America, as well as 4its AccelTRA ready-to-sterilize (RTS)/ready-to-use (RTU) components product line with the RTS opportunity open now for customers needing a high-performing elastomer and lead-time program help outside North America.

Scope of the Report

Report Attribute	Details
Market Size Value in 2021	USD 35.4 Billion
The revenue forecast in 2028	USD 68.49 Billion
Growth Rate	CAGR of 8.1% from 2022 to 2028.
Historical data	2017 – 2020
Forecast period	2022 – 2028
Region covered	North America, Europe, Asia-Pacific, South America, and Middle East & Africa
Key companies Profiled	The companies include Amcor Limited, DuPont De Nemours, Inc., 3M Company, West Pharmaceutical Services, Inc., ProAmpac, Sonoco, Tekni-Plex, Orchid, Oliver Healthcare Packaging and Technipaq are key players.

Market Modelling

By Packaging Type

• Thermoform trays
• Sterile Bottles/Containers
• Vials & Ampoules
• Sterile Closures
• Pre- Filled Syringes
• Blister & clamshells
• IV Bags & Pouches
• Sterile Wraps
• Others

By Material

• Plastics
• Glass
• Metal
• Paper & Paperboard

By Application

• Pharmaceuticals & Biological
• Surgical & Medical Instruments
• Food & Beverage Packaging
• Others

By Region

• North America
• Europe
• Asia-Pacific
• South America

The Middle East & Africa

Precision Parts Market

Global Dual Band GNSS Market

Nail Art Printer Market

Commercial Coffee Machine Market Report

Europe Resilient Flooring Market Excel Data

Edible Vegetable Oil Market

Pre-Engineered Building Market

Live Cell Imaging Market

Navigation Systems Market